Kailera Therapeutics, Inc. KLRA
11.02 USD -0.56 (-4.84%)
Regular-session close
11.02 0.00 0.00%
After hours · Nov 20, 4:01 PM ET
11.00 Day range 11.87
9.76 52-week range 28.23
- YTD
- -57.62%
- 1 year
- -57.62%
Held by funds
72 US ETFs and mutual funds hold KLRA · largest positions
- FBIOX 0.32% of fund $18.93M
- XBI 0.17% of fund $18.56M
- IWM 0.02% of fund $17.10M
- VTI 0.00% of fund $13.48M
- CGOAX 0.31% of fund $10.08M
- VB 0.01% of fund $9.54M
- FGCKX 0.01% of fund $8.00M
- FSSNX 0.02% of fund $7.76M
- FBGRX 0.01% of fund $6.70M
- CSVYX 0.24% of fund $6.02M
- VBK 0.01% of fund $5.31M
- VXF 0.01% of fund $5.30M
- SHSKX 0.08% of fund $4.89M
- IWO 0.03% of fund $4.25M
- SHSSX 0.06% of fund $3.81M
- COVAX 0.43% of fund $3.75M
- OZEM 5.88% of fund $3.37M
- VTWO 0.02% of fund $3.06M
- SCHA 0.01% of fund $2.88M
- FSMAX 0.01% of fund $2.26M
Ownership
Held by insiders 8.90%
Held by institutions 92.31%
Float held by institutions 101.32%
Institutions 186
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Bain Capital Investors Llc | 20.22% | 26,255,581 | 289.34M | Sep 29, 2026 |
| Bain Capital Life Sciences Investors, LLC | 17.39% | 22,583,268 | 248.87M | Sep 29, 2026 |
| RTW Investments LP | 8.30% | 10,776,820 | 118.76M | Sep 29, 2026 |
| Canada Pension Plan Investment Board | 5.63% | 7,304,688 | 80.50M | Sep 29, 2026 |
| Atlas Venture Life Science Advisors, LLC | 3.98% | 5,171,282 | 56.99M | Sep 29, 2026 |
| FMR, LLC | 3.59% | 4,659,885 | 51.35M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.69% | 2,191,928 | 24.16M | Jul 30, 2026 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 1.28% | 1,657,199 | 18.26M | Sep 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 0.94% | 1,221,869 | 13.46M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 0.92% | 1,199,783 | 13.22M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 0.91% | 1,180,411 | 13.01M | Jun 29, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.70% | 904,283 | 9.97M | Jun 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAIN CAPITAL INVESTORS, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 19, 2026 | 0 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 19, 2026 | 0 |
| JIANGSU HENGRUI PHARMACEUTICALS CO. LTD. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Apr 19, 2026 | 2,034,130 |
| KAPLAN ANDREW T | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 19, 2026 | 0 |
| KOPPEL ADAM M | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 19, 2026 | 0 |
| RENAUD RONALD C JR | Chief Executive Officer | Conversion of Exercise of derivative security | Jun 8, 2026 | 38,094 |
